Addus HomeCare Corporation (NASDAQ:ADUS) Receives $142.57 Average Target Price from Analysts

Shares of Addus HomeCare Corporation (NASDAQ:ADUS - Get Free Report) have been given a consensus rating of "Buy" by the eight ratings firms that are presently covering the firm, MarketBeat reports. Six analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. The average 12-month price objective among brokerages that have issued ratings on the stock in the last year is $142.57.

Several research analysts have weighed in on the company. Stephens reiterated an "overweight" rating and set a $142.00 price objective on shares of Addus HomeCare in a research report on Wednesday, March 12th. JMP Securities reiterated a "market outperform" rating and set a $150.00 price objective on shares of Addus HomeCare in a research report on Friday, June 20th. Macquarie reiterated an "outperform" rating and set a $133.00 price objective on shares of Addus HomeCare in a research report on Tuesday, June 10th. Finally, Wall Street Zen lowered Addus HomeCare from a "buy" rating to a "hold" rating in a report on Saturday, June 21st.

Addus HomeCare Stock Performance

ADUS stock traded down $0.52 during trading hours on Wednesday, hitting $115.12. 285,580 shares of the stock were exchanged, compared to its average volume of 166,556. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.20. The firm has a market capitalization of $2.12 billion, a P/E ratio of 25.99, a P/E/G ratio of 1.63 and a beta of 0.81. The company has a 50-day simple moving average of $110.24 and a two-hundred day simple moving average of $111.66. Addus HomeCare has a 12 month low of $88.96 and a 12 month high of $136.72.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last posted its quarterly earnings data on Monday, May 5th. The company reported $1.42 earnings per share for the quarter, topping the consensus estimate of $1.33 by $0.09. The firm had revenue of $337.71 million for the quarter, compared to analysts' expectations of $341.66 million. Addus HomeCare had a return on equity of 9.23% and a net margin of 6.52%. The company's quarterly revenue was up 20.3% compared to the same quarter last year. During the same quarter last year, the business earned $1.21 EPS. On average, analysts forecast that Addus HomeCare will post 4.59 earnings per share for the current fiscal year.

Insider Transactions at Addus HomeCare

In related news, EVP Michael D. Wattenbarger sold 2,045 shares of the firm's stock in a transaction dated Tuesday, May 27th. The stock was sold at an average price of $115.00, for a total value of $235,175.00. Following the sale, the executive vice president now directly owns 7,796 shares of the company's stock, valued at $896,540. This trade represents a 20.78% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. 4.60% of the stock is currently owned by insiders.

Institutional Trading of Addus HomeCare

Several large investors have recently bought and sold shares of the business. First Hawaiian Bank boosted its stake in Addus HomeCare by 2.0% in the first quarter. First Hawaiian Bank now owns 4,898 shares of the company's stock valued at $484,000 after buying an additional 95 shares in the last quarter. Inspire Investing LLC boosted its stake in Addus HomeCare by 9.3% in the first quarter. Inspire Investing LLC now owns 3,470 shares of the company's stock valued at $343,000 after buying an additional 294 shares in the last quarter. Rhumbline Advisers boosted its stake in Addus HomeCare by 1.3% in the first quarter. Rhumbline Advisers now owns 52,483 shares of the company's stock valued at $5,190,000 after buying an additional 649 shares in the last quarter. Strs Ohio acquired a new stake in Addus HomeCare in the first quarter valued at about $653,000. Finally, Intech Investment Management LLC boosted its stake in Addus HomeCare by 44.7% in the first quarter. Intech Investment Management LLC now owns 14,362 shares of the company's stock valued at $1,420,000 after buying an additional 4,439 shares in the last quarter. 95.35% of the stock is owned by institutional investors and hedge funds.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.